Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer

Trial Profile

Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2013

At a glance

  • Drugs Docetaxel (Primary) ; Bicalutamide; Dexamethasone; Estramustine; Goserelin
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Aug 2012 Actual end date May 2011 added as reported by ClinicalTrials.gov.
    • 13 Aug 2012 Actual initiation date Jan 2001 added as reported by ClinicalTrials.gov.
    • 08 Dec 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top